经导管药盒系统动脉灌注治疗中、晚期恶性肿瘤30例疗效观察

目的评价中、晚期恶性肿瘤患者经导管药盒系统(PCS)动脉灌注化疗药物及榄香烯乳后的临床疗效。方法63例中、晚期恶性肿瘤患者随机分为A组31例(灌注化疗药物+榄香烯乳)、B组32例(单纯灌注化疗药物),比较2组近期疗效。结果A、B组总有效率分别为66.7%、46.7%,1y生存率分别为56.7%、43.3%,2组比较均具有显著性差异(P<0.05)。结论经PCS动脉灌注化疗药物加用榄香烯乳治疗中、晚期恶性肿瘤可行,且疗效优于单纯灌注化疗药物。

Artery Infusion Therapy via Port-Catheter System for Middle-Late Malignant Tumors: Survey of 30 Cases

OBJECTIVE:To evaluate the clinical outcome of arterial perfusion with chemotherapy medicine together with elemenum emulsion injection solution via Port-Catheter System(PCS)in treating middle-late malignant tumors.METHODS:A total of63patients with middle-late malignant tumors were enrolled,31were randomly assigned to receive arterial perfusion of chemotherapeutics in combination with elemenum emulsion(group A),and32cases to receive single arterial perfusion of chemotherapeutics(group B),the short-term curative effects of the2groups were then compared.RESULTS:The total effec_ tive rate of group A and B were66.7%and46.7%,respectively with one-year survival of which respectively at56.7%and43.3%.There was significant difference between two groups(P<0.05).CONCLUSION:The clinical effect of the arterially pe_ rfused chemotherapeutics in conjunction with elemenum emulsion injection solution via PCS is better than used alone in treating middle-late malignant tumors.